[topsearch__bar__shortcode]

February 3, 2023

Edible Gardens (EDBL) Facing Rough Day After Price Offering

Edible Garden AG Inc. (NASDAQ: EDBL) is a controlled environment farming company that sells its products across the United States. It is looking to take the next big step in its business life cycle and raise finances to expand its scale of operations. As one would expect, EDBL is still struggling to navigate the highly […]

Edible Gardens (EDBL) Facing Rough Day After Price Offering Read More »

Bright Green Corporation (BGXX) Steps Up Its Game

The recent market performance of the US-based cannabis company, Bright Green Corporation (NASDAQ: BGXX) is extremely interesting. The investment appeal sees further improvement by the fact that the company almost entirely belongs to insiders, who appear pretty confident about the direction the company is moving along. Bright Green’s Strong Market Initiative Bright Green Corporation (BGXX)

Bright Green Corporation (BGXX) Steps Up Its Game Read More »

Sidus Space’s (SIDU) Growth Rocket Finds New Hope

Sidus Space Inc. (NASDAQ: SIDU) is a small satellite company that is fighting an uphill battle to establish itself in this dynamic, and highly competitive space. Recently, the company has been seeing a surging gains in its price, aftermarket bulls rush this stock with its recent game-changing developments. Recent Achievements Spark New Confidence Market pessimism

Sidus Space’s (SIDU) Growth Rocket Finds New Hope Read More »

Nordstrom Inc. (JWN) Becomes Investment Target of Ryan Cohen

Nordstrom Inc. (NYSE: JWN) has been seeing a dangerous slowdown in its business that goes as far back as 2020. The department store chain is facing a range of issues on the macroeconomic front impacting its market competitiveness. The new ownership shift comes at a much-needed time for a change. Market Ecstatic over Nordstrom Ownership

Nordstrom Inc. (JWN) Becomes Investment Target of Ryan Cohen Read More »

Magenta Therapeutics (MGTA) Desperately Considers All Its Options

Magenta Therapeutics Inc. (NASDAQ: MGTA) is facing a lethal uphill battle in its fight for survival. This biopharma company saw its prospects flatten after dismal trial results for its flagship candidate. MGNTA Stock Crash in December Magenta Therapeutics Inc. (MGTA) suffered a drastic blow in December, after revealing an update on its lead blood cancer

Magenta Therapeutics (MGTA) Desperately Considers All Its Options Read More »

Genetic Technologies Ltd. (GENE) Keeps The Wins Coming

Genetic Technologies Ltd. (NASDAQ: GENE) is a promising Australian biotech player that has made remarkable strides in the realm of genetic testing and risk identification. The potential this domain has to offer the wider healthcare sector is enormous. Recent developments have put this already winning player in the market spotlight. Generic Technologies Announces Groundbreaking Partnership

Genetic Technologies Ltd. (GENE) Keeps The Wins Coming Read More »

ReShape Life Sciences (RSLS) Stock in Trouble

ReShape Life Sciences Inc. (NASDAQ: RSLS) is a company specializing in medical equipment that is geared towards patients suffering from heart conditions and obesity to metabolic ailments. What was once a star performer with a presence in the US, Europe, Australia, and other international markets has fallen to deadly lows, with imminent challenges. Plummeting RSLS

ReShape Life Sciences (RSLS) Stock in Trouble Read More »